Lokavant, a company specializing in clinical trial intelligence platforms, has launched a new product called "Spectrum." Spectrum is an AI-centered product designed to optimize clinical trials by predicting and managing trial timelines and costs in real time.

Spectrum holds several key features that aid in effective clinical trial management. These include comprehensive site startup sequencing and modeling through AI and machine learning, high-throughput scenario planning, precise study enrollment predictions, accurate financial and budget forecasting, data-driven recommendations for study progression, and efficient automatic reporting and data exportation capabilities.

Lokavant asserts multiple benefits of using Spectrum. It enables detailed analysis and optimization at the onset and midway through clinical trials, allowing continuous assessment and improvement. It eliminates manual interference in financial forecasting and dynamically adjusts budgets in line with timeline modifications. Its ability to offer real-time recommendations aids in trial steerage and its predictive analytics applications help detect noncompliance issues, improve enrollment forecast accuracy, and save time and money.